Senior Principal, Brand and Commercial Strategy / Financial Institutions Consulting, IQVIA
Associate Principal, Brand and Commercial Strategy, IQVIA
Discover how emerging biopharma companies can navigate today’s challenging investment climate by refining their operational expenditure (OPEX) strategies. This session focuses on the commercialization of New Chemical Entities (NCEs) and Biologics License Applications (BLAs), offering actionable insights to align go-to-market plans with true clinical differentiation. Learn how to build lean, effective commercial organizations that drive toward breakeven without compromising impact.
Ready to future-proof your biopharma strategy? Register now to gain expert insights and stay competitive in a shifting investment landscape.
Our capabilities in healthcare data, AI, and analytics equip financial services with unmatched insights, fostering smart investments and strategic decisions.
